January 2, 2018: Escalating Our Potential to Save Lives
We’re excited to announce that we have recently received approval for MedAware’s second year funding from the Israel Innovation Authority. The Israeli government’s support validates the value of MedAware’s game-changing medication surveillance solutions, as well as our technological progress, roadmap and market potential to combat this serious issue.
November 17, 2017: Talking the Healthcare Triple Aim On the Relentless Health Value Podcast
I am thrilled to announce that MedAware has been included in this week’s Relentless Health Value podcast. The series highlights healthcare entrepreneurs and executives who are pursuing the Triple Aim of optimizing population health and improving the patient experience, while controlling costs. The interviews seek to amplify the innovative work of forward-thinking healthcare leaders to inspire others in the industry.
August 29, 2017: A Conversation with Israel’s Minister of Health
Following our recognition as one of the winners in the “Leading Healthcare Initiatives in 2017” contest (sponsored by the Reboot forum and Globes magazine), we received an invitation to speak with the Israeli Ministry of Health (MOH) Rabbi Yaakov Litzman. We happily accepted this offer as we are passionate about the topic of patient safety.
August 16, 2017: Scaling Up
We’re thrilled to share the news that we have recently closed on an $8-million Series A round of funding, backed by investors BD (Becton, Dickinson and Company), Yingcheng City Fubon Technology, OurCrowd and Gefen Capital. This financing, coupled with the grants we’ve received from Israel’s Innovation Authority and the BIRD Foundation, as well as from the European Commission as part of its Horizon2020 program, means we’ve raised a total of $12 million to date.